16/10/2014 08:42:21

EXINI to arrange Bone Scan Index (BSI) symposium at important annual European congress

Lund, Sweden, 2014-10-16 09:42 CEST (GLOBE NEWSWIRE) --

EXINI and FUJIFILM RI Pharma will arrange a Bone Scan Index (BSI) symposium on

October 20th at this year’s EANM-congress (European Association of Nuclear

Medicine) held in Gothenburg, October 18-22.

The symposium called ”Bone Scan Index (BSI) A Nuclear Medicine Biomarker in

Metastatic Prostate Cancer”, commence at 13.00 p.m. For more information >>

Program

”The symposium provide a unique opportunity for invited physicians within

nuclear medicine, to learn more about the imaging biomarker BSI and its

clinical applications. Arranging it together with our partner FUJIFILM RI

Pharma adds extensive clinical experience and insights gained from the success

of our product EXINI boneBSI (Bonenavi) on the Japanese market ”, comments

Magnus Aurell, CEO, EXINI Diagnostics AB.

Throughout the congress, several academic studies based upon use of the

software EXINI boneBSI and its BSI-calculating capacity, will be presented:

OP365: Prognostic value of bone scan index for treatment response and survival

in patients with high-risk prostate cancer. M. Reza, A. Bjartell, M. Ohlsson,

R. Kaboteh, P. Wollmer, L. Edenbrandt, E. Trägård

P491: Analytical validation of automated bone scan index as a candidate imaging

biomarker for advanced prostate cancer. A. Anand, L. Edenbrandt, A. Bjartell,

D. Minarik

P502: Reproducibility of automated bone scan index in patients with advanced

prostate cancer. A. Anand, L. Båth, R. Kaboteh, A. Bjartell, L. Edenbrandt

P786: Routine usefulness analysis of computer assisted diagnosis (CAD) software

for bone scan index L. Ferrer, M. Colombie, D. Rusu, D. Goulon, B. Jamet, N.

Varmenot, F. Kraeber-Bodere, C. Rousseau

More on Bone Scan Index (BSI):

BSI is an imaging biomarker providing fast, accurate and quantifiable

information to be used for diagnosis and stratification and the monitoring of

treatment response. It also provides increased accuracy in prognoses involving

patients suffering from skeletal metastases originating from prostate- or

breast cancer.

What is more, BSI has demonstrated its importance in the process of developing

new drugs, thus proving itself just as important for clinical use as for the

pharmaceutical industry. EXINI boneBSI is the only software capable of

extracting BSI-values for both these purposes.

www.bonescanindex.org

www.exini.com/software-bone-bsi/

For more information, please contact:

Magnus Aurell, CEO

Phone: +46 46 286 54 25

E-mail: magnus.aurell@exini.com

About EXINI Diagnostics AB (publ)

EXINI Diagnostics AB (publ) offers advanced solutions for medical decision

support to hospitals worldwide. The system is based on advanced image analysis

by artificial intelligence and can make its own interpretation of medical

images and provide diagnostic suggestions. In this way the system is used as a

decision support for the diagnosing doctor. EXINI is working with products for

the diagnosis of some of the most frequent endemic diseases such as cancer,

coronary heart disease, dementia and Parkinson's disease. The company was

founded in 1999 by Professor Lars Edenbrandt. EXINI is listed on the stock

market NASDAQ OMX First North and has about 600 shareholders. Principal owner

is Bo Håkansson. Consensus acts as Certified Adviser.

________________________________________________________________________

EXINI Diagnostics AB, Ideon Science Park, Scheelevägen 27, SE-223 70

Lund, Sweden

Phone: +46 46 286 54 20, Fax: +46 46 286 54 29, info@exini.com,

www.exini.com

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
27 Mar
OMXC20
  Det kan være næsten lige så vanedannende som narkotika og cigaretter at sidde dag efter dag og føl..
30
23 Mar
I:DAX
@marc55.   Lad mig give dig et velment råd.   Jeg er ikke en gammel sur mand (hverken gammel eller s..
19
28 Mar
BAVA
Regnearket er bygget op, på den måde, at det udregner Gak prisen løbende. I GAK prisen, er der altså..
17
26 Mar
 
Aktieugebrevet skriver:   Zealand Pharma kan stå foran stor værdiskabelse Zealand Pharma aktien har ..
17
28 Mar
 
Det var da på tide. De skulle aldrig have åbnet. Man kan da ikke starte et firma, der åbenlyst laver..
14
23 Mar
VWS
Dong Energy og Vestas får meldinger om off shore industrien, hvor de store olieselskaber øjnene muli..
14
28 Mar
 
Nej. Det er derimod latterligt, at Uber skal være ulovligt i dette i forvejen over regulerede lortel..
13
27 Mar
OMXC20
Bla bla bla bla bla Du er snart være end mig mht. Mig og Danske bank😄 Er der ikke snart noget nyt..
12
24 Mar
DANSKE
Hr. Borgen og kongsmart sad i kantinen og så gårdsdagens nyheder i tv, da Der Tonede et indslag fre..
12
23 Mar
RTX
Altså tillykke med, at du har dig en aktie, der stiger.. Men come on.. Man bliver bare lidt træt af ..
12

Form 8.3 - Bovis Homes Group Plc

29/03/2017 13:51:08
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser: UniCredit SpA (b) Owner or controller of interests an..

HSBC Bank Plc : Form 8.5 (EPT/RI) - Galliford Try PLC

29/03/2017 10:20:13
FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Name of exempt principal trader: HSBC BANK PLC (b) Name of offeror/offe..

Alliance Trust PLC : Transaction in Own Shares

29/03/2017 07:01:36
29 March 2017  Alliance Trust PLC TRANSACTION IN OWN SHARES  The Board of Alliance Trust PLC ("the Company") announces that on 28 March 2017 the Company purchased for cancellation 257,300 ordinary shares of 2.5p each at a price of 681.5023p per share.  Therefore, the total number of voting rights in the Company is now 364,597,266.    The above figure (364,597,266) may be used by sharehold..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Under Armour, Inc. To Contact The Firm
2
RigNet deploys its first deep water 4G LTE system in the Gulf of Mexico and announces dramatic capacity increases to its state-of-the-art licensed 4G wireless network
3
FILO MINING REPORTS 2016 RESULTS
4
Applied Materials Prices $2.2 Billion of Senior Unsecured Notes
5
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Files Class Action Suit Against GigPeak, Inc.

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Euroinvestor A/S 2017   Disclaimer and Terms of Use
Quote information is delivered by Interactive Data.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
29 March 2017 16:13:50
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20170324.2 - EUROWEB5 - 2017-03-29 17:13:50 - 2017-03-29 16:13:50 - 1000 - Website: OKAY